W8AD Stock Overview
Operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.82 |
| 52 Week High | US$24.17 |
| 52 Week Low | US$7.67 |
| Beta | 0.68 |
| 11 Month Change | -13.47% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -74.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| W8AD | GB Consumer Retailing | GB Market | |
|---|---|---|---|
| 7D | -0.3% | -0.8% | -0.7% |
| 1Y | n/a | 20.3% | 6.7% |
Return vs Industry: Insufficient data to determine how W8AD performed against the UK Consumer Retailing industry.
Return vs Market: Insufficient data to determine how W8AD performed against the UK Market.
Price Volatility
| W8AD volatility | |
|---|---|
| W8AD Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 3.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in GB Market | 9.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: W8AD's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine W8AD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1909 | 268,500 | Tim Wentworth | www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
| W8AD fundamental statistics | |
|---|---|
| Market cap | €6.61b |
| Earnings (TTM) | -€5.20b |
| Revenue (TTM) | €130.22b |
0.1x
P/S Ratio-1.3x
P/E RatioIs W8AD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| W8AD income statement (TTM) | |
|---|---|
| Revenue | US$145.53b |
| Cost of Revenue | US$118.79b |
| Gross Profit | US$26.75b |
| Other Expenses | US$32.56b |
| Earnings | -US$5.81b |
Last Reported Earnings
May 31, 2024
Next Earnings Date
Oct 15, 2024
| Earnings per share (EPS) | -6.73 |
| Gross Margin | 18.38% |
| Net Profit Margin | -3.99% |
| Debt/Equity Ratio | 57.8% |
How did W8AD perform over the long term?
See historical performance and comparison